http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2465414

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 1978
issn 1078-0432
1557-3265
issueIdentifier 7
pageRange 1966-1978
publicationName Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage 1966
bibliographicCitation Wu Y, Chen C, Sun X, Shi X, Jin B, Ding K, Yeung SC, Pan J. Cyclin-dependent kinase 7/9 inhibitor SNS-032 abrogates FIP1-like-1 platelet-derived growth factor receptor α and bcr-abl oncogene addiction in malignant hematologic cells. Clin Cancer Res. 2012 Apr 01;18(7):1966–78. doi: 10.1158/1078-0432.ccr-11-1971. PMID: 22447844.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b22d665c679348bf2232dd569dc93bad
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a95397d4b2b61bc43a85921d279f6090
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f734d464a35c6e09595598d86db6c47a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3081-7164
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0815f59a6a7008f8c00a62fd12160f24
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7128-2947
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb8a2656b4a4e047df29ad077a50032a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_52992343fc92c5cd30140fef81543f5b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9016-812X
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8a827f11b0ce272d819fea42db2ad6fb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fe10ca7e352e58069ac158ada8981cd9
date 2012-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/22447844
https://doi.org/10.1158/1078-0432.ccr-11-1971
isPartOf https://portal.issn.org/resource/ISSN/1557-3265
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794
https://portal.issn.org/resource/ISSN/1078-0432
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Cyclin-Dependent Kinase 7/9 Inhibitor SNS-032 Abrogates FIP1-like-1 Platelet-Derived Growth Factor Receptor α and Bcr-Abl Oncogene Addiction in Malignant Hematologic Cells
discusses http://id.nlm.nih.gov/mesh/M0021333
http://id.nlm.nih.gov/mesh/M0328265
http://id.nlm.nih.gov/mesh/M0181432
http://id.nlm.nih.gov/mesh/M0457817
http://id.nlm.nih.gov/mesh/M0028197
http://id.nlm.nih.gov/mesh/M0195409
http://id.nlm.nih.gov/mesh/M0023875
http://id.nlm.nih.gov/mesh/M0024527
http://id.nlm.nih.gov/mesh/M0230514
http://id.nlm.nih.gov/mesh/M0465591
http://id.nlm.nih.gov/mesh/M0015641
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D010080Q000494
http://id.nlm.nih.gov/mesh/D015514Q000037
http://id.nlm.nih.gov/mesh/D013844Q000494
http://id.nlm.nih.gov/mesh/D016044Q000037
http://id.nlm.nih.gov/mesh/D020796Q000037
http://id.nlm.nih.gov/mesh/D039221Q000037
http://id.nlm.nih.gov/mesh/D015464Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D002460
http://id.nlm.nih.gov/mesh/D002453Q000187
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D015398Q000187
http://id.nlm.nih.gov/mesh/D010766Q000187
http://id.nlm.nih.gov/mesh/D008807
http://id.nlm.nih.gov/mesh/D016044Q000378
http://id.nlm.nih.gov/mesh/D018844Q000037
http://id.nlm.nih.gov/mesh/D039221Q000378
http://id.nlm.nih.gov/mesh/D042863Q000037
http://id.nlm.nih.gov/mesh/D015514Q000378
http://id.nlm.nih.gov/mesh/D015153
http://id.nlm.nih.gov/mesh/D017209Q000187
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D020133
http://id.nlm.nih.gov/mesh/D000095043
http://id.nlm.nih.gov/mesh/D015464Q000378
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D020796Q000378
http://id.nlm.nih.gov/mesh/D020796Q000235
http://id.nlm.nih.gov/mesh/D016044Q000235
http://id.nlm.nih.gov/mesh/D008819
http://id.nlm.nih.gov/mesh/D051379
http://id.nlm.nih.gov/mesh/D049109Q000187
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D015514Q000235
http://id.nlm.nih.gov/mesh/D023041
http://id.nlm.nih.gov/mesh/D042863Q000378
http://id.nlm.nih.gov/mesh/D045744
http://id.nlm.nih.gov/mesh/D015464Q000235
http://id.nlm.nih.gov/mesh/D018844Q000378
http://id.nlm.nih.gov/mesh/D039221Q000235
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10067
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6629
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3025986
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5bf20507b757dd624886dac9baef5c7d
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_70643a11490fc61985b1557ea294f50b
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9727
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a64d6d2119c98ada978c845df2abbea
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8908d9f016f678ac2f17eeac90bb5212
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_99224609a387991b01596a7dc28b7e4d
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5fda3cf5b60746fa11ec174d7d901401
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6002c6713f40e8a35d365605542e72b0
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.7.7.6
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10364

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID613
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID81608
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1022
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1025
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128433595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247580988
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5156
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25267
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25

Total number of triples: 104.